Sherie L. Morrison

14.7k total citations · 2 hit papers
242 papers, 11.4k citations indexed

About

Sherie L. Morrison is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Sherie L. Morrison has authored 242 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 182 papers in Radiology, Nuclear Medicine and Imaging, 164 papers in Molecular Biology and 82 papers in Immunology. Recurrent topics in Sherie L. Morrison's work include Monoclonal and Polyclonal Antibodies Research (180 papers), Glycosylation and Glycoproteins Research (107 papers) and Protein purification and stability (32 papers). Sherie L. Morrison is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (180 papers), Glycosylation and Glycoproteins Research (107 papers) and Protein purification and stability (32 papers). Sherie L. Morrison collaborates with scholars based in United States, South Korea and Canada. Sherie L. Morrison's co-authors include Vernon T. Oi, Mi‐Hua Tao, Ann Wright, Susumu Tonegawa, Stephen D. Gillies, L A Herzenberg, Manuel L. Penichet, Elvin A. Kabat, Koteswara R. Chintalacharuvu and M. Josefina Coloma and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Sherie L. Morrison

239 papers receiving 10.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene

1983 1.2k citations Sherie L. Morrison et al. profile →
Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.

1984 698 citations Sherie L. Morrison et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sherie L. Morrison United States	53	6.8k	6.6k	4.4k	1.7k	928	242	11.4k
Ian S. Trowbridge United States	66	8.2k 1.2×	3.5k 0.5×	5.4k 1.2×	1.6k 1.0×	781 0.8×	139	14.5k
Ian F. C. McKenzie Australia	64	6.0k 0.9×	4.3k 0.7×	8.0k 1.8×	1.8k 1.1×	2.0k 2.1×	459	15.6k
Ellen S. Vitetta United States	58	3.7k 0.5×	3.3k 0.5×	6.9k 1.6×	1.9k 1.1×	564 0.6×	250	11.4k
Stephen D. Gillies United States	50	4.0k 0.6×	2.4k 0.4×	4.5k 1.0×	3.7k 2.2×	1.4k 1.5×	153	9.8k
Michael Potter United States	62	6.8k 1.0×	4.0k 0.6×	4.6k 1.0×	2.0k 1.2×	1.2k 1.3×	284	12.7k
Michael S. Neuberger United Kingdom	74	10.2k 1.5×	5.7k 0.9×	10.7k 2.4×	2.0k 1.2×	1.6k 1.7×	165	20.0k
Roland E. Kontermann Germany	47	5.1k 0.8×	4.5k 0.7×	2.5k 0.6×	2.6k 1.5×	616 0.7×	183	8.9k
Joyce Taylor‐Papadimitriou United Kingdom	77	12.4k 1.8×	5.6k 0.9×	6.2k 1.4×	4.5k 2.7×	1.5k 1.6×	248	18.2k
Elisabeth Stockert United States	64	8.2k 1.2×	3.0k 0.5×	9.2k 2.1×	5.7k 3.4×	1.8k 1.9×	143	16.4k
Fritz Melchers Switzerland	77	5.9k 0.9×	4.6k 0.7×	14.7k 3.4×	2.4k 1.4×	1.4k 1.5×	326	20.3k

Countries citing papers authored by Sherie L. Morrison

Since Specialization

Citations

This map shows the geographic impact of Sherie L. Morrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherie L. Morrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherie L. Morrison more than expected).

Fields of papers citing papers by Sherie L. Morrison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherie L. Morrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherie L. Morrison. The network helps show where Sherie L. Morrison may publish in the future.

Co-authorship network of co-authors of Sherie L. Morrison

This figure shows the co-authorship network connecting the top 25 collaborators of Sherie L. Morrison. A scholar is included among the top collaborators of Sherie L. Morrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherie L. Morrison. Sherie L. Morrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zettlitz, Kirstin A., Felix B. Salazar, Reiko Yamada, et al.. (2022). 89Zr-ImmunoPET Shows Therapeutic Efficacy of Anti-CD20-IFNα Fusion Protein in a Murine B-cell Lymphoma Model. Molecular Cancer Therapeutics. 21(4). 607–615. 3 indexed citations

Yamada, Reiko, et al.. (2019). In Vivo Efficacy of Anti-CD20-Interferon-Gamma Fusion Protein Against Syngeneic B Cell Lymphoma Is Mediated By Natural Killer Cells. Blood. 134(Supplement_1). 1575–1575. 1 indexed citations

Xu, Shili, Tianyuan Zhou, K. Ryan Trinh, et al.. (2019). An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1−HK2+ Multiple Myeloma. Cancer Research. 79(10). 2748–2760. 44 indexed citations

Young, Patricia A., Reiko Yamada, Satiro De Oliveira, et al.. (2018). Activity of Anti-CD19 Chimeric Antigen Receptor T Cells Against B Cell Lymphoma Is Enhanced by Antibody-Targeted Interferon-Alpha. Journal of Interferon & Cytokine Research. 38(6). 239–254. 7 indexed citations

Daniels‐Wells, Tracy R., et al.. (2015). Genetic Engineering of Antibody Molecules. 1. 1–52. 2 indexed citations

Yoo, Esther M., et al.. (2014). Anti-CD138-Targeted Interferon Is a Potent Therapeutic Against Multiple Myeloma. Journal of Interferon & Cytokine Research. 35(4). 281–291. 21 indexed citations

Yoo, Esther M., Li Yu, Letitia A. Wims, David Theo Goldberg, & Sherie L. Morrison. (2010). Differences in N-glycan structures found on recombinant IgA1 and IgA2 produced in murine myeloma and CHO cell lines. mAbs. 2(3). 320–334. 28 indexed citations

Afshar, Sepideh, Tsuneaki Asai, & Sherie L. Morrison. (2009). Humanized ADEPT comprised of an engineered human purine nucleoside phosphorylase and a tumor targeting peptide for treatment of cancer. Molecular Cancer Therapeutics. 8(1). 185–193. 22 indexed citations

Gurbaxani, Brian M. & Sherie L. Morrison. (2005). Development of new models for the analysis of Fc–FcRn interactions. Molecular Immunology. 43(9). 1379–1389. 21 indexed citations

10.

Trinh, Ryan, et al.. (2003). Optimization of codon pair use within the (GGGGS)3 linker sequence results in enhanced protein expression. Molecular Immunology. 40(10). 717–722. 85 indexed citations

11.

Penichet, Manuel L., et al.. (2001). Mechanism of Antitumor Activity of a Single-Chain Interleukin-12 IgG3 Antibody Fusion Protein (mscIL-12.her2.IgG3). Journal of Interferon & Cytokine Research. 21(9). 709–720. 21 indexed citations

12.

Zhang, Ke, et al.. (2000). The novel human IgE epsilon heavy chain, epsilon tailpiece, is present in plasma as part of a covalent complex. Molecular Immunology. 37(5). 241–252. 6 indexed citations

13.

Mateo, César, J Lombardero, Ernesto Moreno, et al.. (2000). Removal of Amphipathic Epitopes from Genetically Engineered Antibodies: Production of Modified Immunoglobulins with Reduced Immunogenicity. Hybridoma. 19(6). 463–471. 33 indexed citations

14.

Penichet, Manuel L., et al.. (1999). A Single-Chain IL-12 IgG3 Antibody Fusion Protein Retains Antibody Specificity and IL-12 Bioactivity and Demonstrates Antitumor Activity. The Journal of Immunology. 163(1). 250–258. 68 indexed citations

15.

Penichet, Manuel L., et al.. (1999). In vivo properties of three human HER2/neu-expressing murine cell lines in immunocompetent mice.. PubMed. 49(2). 179–88. 45 indexed citations

16.

Zhang, Huifen, Jinghua Yu, Ednan K. Bajwa, Sherie L. Morrison, & Stephen Tomlinson. (1999). Targeting of functional antibody-CD59 fusion proteins to a cell surface. Journal of Clinical Investigation. 103(1). 55–61. 36 indexed citations

17.

Penichet, Manuel L., Eric T. Harvill, & Sherie L. Morrison. (1997). Antibody-IL-2 fusion proteins: a novel strategy for immune protection.. PubMed. 8(3). 106–18. 10 indexed citations

18.

Phillips, Martin L., Mi‐Hua Tao, Sherie L. Morrison, & Verne N. Schumaker. (1994). Human/mouse chimeric monoclonal antibodies with human IgG1, IgG2, IgG3 and IgG4 constant domains: Electron microscopic and hydrodynamic characterization. Molecular Immunology. 31(15). 1201–1210. 34 indexed citations

19.

Batra, Surinder K., Carol J. Wikstrand, Charles N. Pegram, et al.. (1994). Mouse/Human Chimeric Me1-14 Antibody: Genomic Cloning of the Variable Region Genes, Linkage to Human Constant Region Genes, Expression, and Characterization. Hybridoma. 13(2). 87–97. 14 indexed citations

20.

Bonagura, Vincent R., et al.. (1992). Mapping Rheumatoid Factor Binding Sites Using Genetically Engineered, Chimeric IgG Antibodies. DNA and Cell Biology. 11(3). 245–252. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact